Literature DB >> 7051230

Problems in determination of antibiotic synergism in vitro.

C W Norden.   

Abstract

The methods and criteria for testing for synergy were compared by use of 22 strains of Klebsiella pneumoniae and a combination of cephalothin and gentamicin. With the checkerboard technique, the frequency of synergy varied with the criterion employed. When the rate of killing of bacteria by antibiotics was measured, results varied according to the size of inoculum. Comparison of the checkerboard and killing-curve techniques showed poor correlation in terms of the frequency of strains showing synergy. Because clinical observations suggest that treatment of serious infections with combinations of antibiotics that are synergistic in vitro may enhance survival, the methods and criteria for testing for synergy should be standardized.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7051230     DOI: 10.1093/clinids/4.2.276

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  9 in total

1.  In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria.

Authors:  E Debbia; A Pesce; G C Schito
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

2.  Decimal assay for additivity of drugs permits delineation of synergy and antagonism.

Authors:  C C Sanders; W E Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

3.  Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics.

Authors:  P Paglia; G Molinari; A Pesce; E A Debbia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

4.  Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections.

Authors:  K Leszczyńska; A Namiot; K Cruz; F J Byfield; E Won; G Mendez; W Sokołowski; P B Savage; R Bucki; P A Janmey
Journal:  J Appl Microbiol       Date:  2010-10-21       Impact factor: 3.772

5.  Modulation of exogenous antibiotic activity by host cathelicidin LL-37.

Authors:  Katarzyna Leszczyńska; Andrzej Namiot; Paul A Janmey; Robert Bucki
Journal:  APMIS       Date:  2010-09-14       Impact factor: 3.205

6.  Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.

Authors:  L R Peterson; D N Gerding; J A Moody; C E Fasching
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

7.  In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.

Authors:  J A Moody; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

8.  Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa.

Authors:  D M Cappelletty; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.

Authors:  B J McGrath; K C Lamp; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.